Search This Blog

Tuesday, November 12, 2019

Satsuma Pharmaceuticals EPS misses by $1.25

Satsuma Pharmaceuticals (NASDAQ:STSA): Q3 GAAP EPS of -$2.26 misses by $1.25.
Cash and equivalents of $118.9M.
Press Release
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)